CNTA - CENTESSA PHARMACEUTICALS PLC
This page shows which of the focused investors we track hold CNTA and how their positions changed, so you can see how much conviction the group has in the stock.
In Q1 2026 it was held by 1 manager with an aggregate reported value of $73.66M, which is 0.01% of the combined portfolio.
As of Q1 2026, 1 tracked institutional manager held CNTA (CENTESSA PHARMACEUTICALS PLC) with an aggregate reported value of $73.66M — 0.01% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades CNTA — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q1 2026
- Ticker
- CNTA
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Lee Ainslie - Maverick Capital | 0.86% | Add +12.8% | 1,854,488 | $73.66M |
Loading holder history for CNTA…